AcquisitionOther
Viatris Inc acquired Pacira BioSciences, Advancing Its Innovative Medicines Strategy
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Viatris Inc -> Pacira BioSciences, Advancing Its Innovative Medicines Strategy · $36.50
Innovative Medicines Commercial, Market Access, Medical Affairs and Global R&D Capabilities • Expected to Be Synergistic With Viatris’ Fast-Acting Meloxicam Opportunity • Deal Anticipated to Close By the End of 2026 and to Be Immediately Accretive to Viatris’
Open source record (SEC) ↗